| Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells B Ruf, B Heinrich, TF Greten Cellular & molecular immunology 18 (1), 112-127, 2021 | 246 | 2021 |
| Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma Q Zhang, C Ma, Y Duan, B Heinrich, U Rosato, LP Diggs, L Ma, S Roy, ... Cancer discovery 11 (5), 1248-1267, 2021 | 184 | 2021 |
| CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma LP Diggs, B Ruf, C Ma, B Heinrich, L Cui, Q Zhang, JC McVey, S Wabitsch, ... Journal of hepatology 74 (5), 1145-1154, 2021 | 121 | 2021 |
| Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD S Wabitsch, JD McCallen, O Kamenyeva, B Ruf, JC McVey, J Kabat, ... Journal of hepatology 77 (3), 748-760, 2022 | 100 | 2022 |
| The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma B Heinrich, EM Gertz, AA Schäffer, A Craig, B Ruf, V Subramanyam, ... Gut 71 (6), 1161-1175, 2022 | 94 | 2022 |
| Biomarkers for immunotherapy of hepatocellular carcinoma TF Greten, A Villanueva, F Korangy, B Ruf, M Yarchoan, L Ma, E Ruppin, ... Nature Reviews Clinical Oncology 20 (11), 780-798, 2023 | 91 | 2023 |
| Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin B Ruf, M Bruhns, S Babaei, N Kedei, L Ma, M Revsine, MR Benmebarek, ... Cell 186 (17), 3686-3705. e32, 2023 | 73 | 2023 |
| Steatohepatitis impairs T-cell–directed immunotherapies against liver tumors in mice B Heinrich, ZJ Brown, LP Diggs, M Vormehr, C Ma, V Subramanyam, ... Gastroenterology 160 (1), 331-345. e6, 2021 | 67 | 2021 |
| Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD C Ma, Q Fu, LP Diggs, JC McVey, J McCallen, S Wabitsch, B Ruf, Z Brown, ... Cancer cell 40 (9), 986-998. e5, 2022 | 60 | 2022 |
| Innate lymphoid cells and innate-like T cells in cancer—at the crossroads of innate and adaptive immunity B Ruf, TF Greten, F Korangy Nature Reviews Cancer 23 (6), 351-371, 2023 | 49 | 2023 |
| Activating mucosal-associated invariant T cells induces a broad antitumor response B Ruf, VV Catania, S Wabitsch, C Ma, LP Diggs, Q Zhang, B Heinrich, ... Cancer immunology research 9 (9), 1024-1034, 2021 | 42 | 2021 |
| Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer C Monge, C Xie, Y Myojin, K Coffman, DM Hrones, S Wang, ... Journal for immunotherapy of cancer 11 (2), e005640, 2023 | 40 | 2023 |
| Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting B Ruf, P Jenkinson, D Armour, M Fraser, AJM Watson Journal of telemedicine and telecare 26 (9), 545-551, 2020 | 37 | 2020 |
| Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma B Ruf, S Berchtold, S Venturelli, M Burkard, I Smirnow, T Prenzel, ... Molecular Therapy-Oncolytics 2, 15019, 2015 | 30 | 2015 |
| Anti–PD-1 in combination with trametinib suppresses tumor growth and improves survival of intrahepatic cholangiocarcinoma in mice S Wabitsch, M Tandon, B Ruf, Q Zhang, JD McCallen, JC McVey, C Ma, ... Cellular and Molecular Gastroenterology and Hepatology 12 (3), 1166-1178, 2021 | 26 | 2021 |
| Assessment of current virotherapeutic application schemes:“hit hard and early” versus “killing softly”? B Ruf, UM Lauer Molecular Therapy-Oncolytics 2, 2015 | 21 | 2015 |
| NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice JC McVey, BL Green, B Ruf, JD McCallen, S Wabitsch, V Subramanyam, ... Iscience 25 (2), 2022 | 17 | 2022 |
| Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma. Cancer Discov. 2021; 11: 1248–1267. doi: 10.1158/2159-8290 Q Zhang, C Ma, Y Duan, B Heinrich, U Rosato, LP Diggs, L Ma, S Roy, ... CD-20-0304.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 15 | |
| Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models S Wabitsch, JC McVey, C Ma, B Ruf, O Kamenyeva, JD McCallen, ... Iscience 24 (1), 2021 | 14 | 2021 |
| Checkpoint inhibitors modulate plasticity of innate lymphoid cells in peripheral blood of patients with hepatocellular carcinoma B Heinrich, B Ruf, V Subramanyam, Y Myojin, CW Lai, AJ Craig, J Fu, ... Frontiers in Immunology 13, 849958, 2022 | 9 | 2022 |
